291 related articles for article (PubMed ID: 33884496)
1. Sporadic inclusion body myositis and primary Sjogren's syndrome: an overlooked diagnosis.
Chung SH; Bent EI; Weiss MD; Gardner GC
Clin Rheumatol; 2021 Oct; 40(10):4089-4094. PubMed ID: 33884496
[TBL] [Abstract][Full Text] [Related]
2. The association of sporadic inclusion body myositis and Sjögren's syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype.
Rojana-udomsart A; Needham M; Luo YB; Fabian V; Walters S; Zilko PJ; Mastaglia FL
Clin Neurol Neurosurg; 2011 Sep; 113(7):559-63. PubMed ID: 21507567
[TBL] [Abstract][Full Text] [Related]
3. Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis.
Amlani A; Choi MY; Tarnopolsky M; Brady L; Clarke AE; Garcia-De La Torre I; Mahler M; Schmeling H; Barber CE; Jung M; Fritzler MJ
Front Immunol; 2019; 10():745. PubMed ID: 31024569
[No Abstract] [Full Text] [Related]
4. A Patient with Sjogren's Syndrome and Subsequent Diagnosis of Inclusion Body Myositis and Light-Chain Amyloidosis.
Hom J; Marwaha S; Postolova A; Kittle J; Vasquez R; Davidson J; Kohler J; Dries A; Fernandez-Betancourt L; Majcherska M; Dearlove J; Raghavan S; Vogel H; Bernstein JA; Fisher P; Ashley E; Sampson J; Wheeler M;
J Gen Intern Med; 2019 Jun; 34(6):1058-1062. PubMed ID: 30887439
[TBL] [Abstract][Full Text] [Related]
5. Anti-Sjögren's-syndrome-related antigen A autoantibodies (Anti-SSA antibody) and meningoencephalitis: Sjögren's syndrome waiting to be unveiled? A case series and review of literature.
Mittal GK; Mittal S; Kaur H; Stephen SR; Sekhar S; Sureshbabu S; Sandhya P
Rheumatol Int; 2021 Oct; 41(10):1855-1866. PubMed ID: 33040168
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus Erythematosus.
Rietveld A; van den Hoogen LL; Bizzaro N; Blokland SLM; Dähnrich C; Gottenberg JE; Houen G; Johannsen N; Mandl T; Meyer A; Nielsen CT; Olsson P; van Roon J; Schlumberger W; van Engelen BGM; Saris CGJ; Pruijn GJM
Front Immunol; 2018; 9():1200. PubMed ID: 29922285
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of anti-NT5C1A antibodies in Japanese patients with autoimmune rheumatic diseases in comparison with other patient cohorts.
Muro Y; Nakanishi H; Katsuno M; Kono M; Akiyama M
Clin Chim Acta; 2017 Sep; 472():1-4. PubMed ID: 28687351
[TBL] [Abstract][Full Text] [Related]
8. Refining myositis associated with primary Sjögren's syndrome: data from the prospective cohort ASSESS.
Felten R; Giannini M; Nespola B; Lannes B; Levy D; Seror R; Vittecoq O; Hachulla E; Perdriger A; Dieude P; Dubost JJ; Fauchais AL; Le Guern V; Larroche C; Dernis E; Guellec D; Cornec D; Sibilia J; Mariette X; Gottenberg JE; Meyer A
Rheumatology (Oxford); 2021 Feb; 60(2):675-681. PubMed ID: 32780813
[TBL] [Abstract][Full Text] [Related]
9. Inclusion-body myositis and primary Sjögren syndrome: mechanisms for shared etiologies.
Limaye VS; Cash K; Smith C; Koszyca B; Patel S; Greenberg SA; Hissaria P
Muscle Nerve; 2020 May; 61(5):570-574. PubMed ID: 32035011
[TBL] [Abstract][Full Text] [Related]
10. Rare case of Sjögren's syndrome antibody (SSA-Ro52kDA)-associated interstitial lung disease and myositis with pipe stem capillaries.
Ramu A; Kaur N; Jain R
BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34620633
[TBL] [Abstract][Full Text] [Related]
11. Myositis in primary Sjögren's syndrome: data from a multicentre cohort.
Colafrancesco S; Priori R; Gattamelata A; Picarelli G; Minniti A; Brancatisano F; D'Amati G; Giordano C; Cerbelli B; Maset M; Quartuccio L; Bartoloni E; Carubbi F; Cipriani P; Baldini C; Luciano N; De Vita S; Gerli R; Giacomelli R; Bombardieri S; Valesini G
Clin Exp Rheumatol; 2015; 33(4):457-64. PubMed ID: 26088683
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of inclusion body myositis in Norway; a population-based clinical epidemiology study.
Dobloug GC; Antal EA; Sveberg L; Garen T; Bitter H; Stjärne J; Grøvle L; Gran JT; Molberg Ø
Eur J Neurol; 2015 Apr; 22(4):672-e41. PubMed ID: 25530508
[TBL] [Abstract][Full Text] [Related]
13. Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement.
Goyal NA; Cash TM; Alam U; Enam S; Tierney P; Araujo N; Mozaffar FH; Pestronk A; Mozaffar T
J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):373-8. PubMed ID: 25857661
[TBL] [Abstract][Full Text] [Related]
14. [Sporadic Inclusion Body Myositis and Autoantibodies].
Yamashita S; Ando Y
Brain Nerve; 2018 Apr; 70(4):449-457. PubMed ID: 29632292
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
[TBL] [Abstract][Full Text] [Related]
16. Myositis with prominent B cell aggregates may meet classification criteria for sporadic inclusion body myositis.
Meyer A; Troyanov Y; Korathanakhun P; Landon-Cardinal O; Leclair V; Allard-Chamard H; Bourré-Tessier J; Makhzoum JP; Isabelle C; Larue S; Grand'Maison F; Massie R; Page ML; Mansour AM; Routhier N; Zarka F; Roy F; Sonnen J; Satoh M; Fritzler M; Hudson M; Senécal JL; Karamchandani J; Ellezam B; O'Ferrall E
Neuromuscul Disord; 2023 Feb; 33(2):169-182. PubMed ID: 36649672
[TBL] [Abstract][Full Text] [Related]
17. [A case of chronic sarcoid myopathy with Basedow's disease and Sjogren's syndrome: A case series of sarcoid myopathy].
Isobe T; Mori-Yoshimura M; Oya Y; Saito Y; Murata M; Nishino I; Takahashi Y
Rinsho Shinkeigaku; 2017 May; 57(5):220-224. PubMed ID: 28450690
[TBL] [Abstract][Full Text] [Related]
18. Anti-RNP positivity in primary Sjögren's syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement.
Abbara S; Seror R; Henry J; Chretien P; Gleizes A; Hacein-Bey-Abina S; Mariette X; Nocturne G
RMD Open; 2019; 5(2):e001033. PubMed ID: 31673417
[TBL] [Abstract][Full Text] [Related]
19. [Primary Sjögren syndrome and inclusion body myositis].
Monteiro P; Coutinho M; Salvador MJ; Malcata A
Acta Reumatol Port; 2009; 34(2A):261-5. PubMed ID: 19474780
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and high-risk indicators of central nervous system involvement in primary Sjögren's syndrome.
Fan W; Par-Young J; Li K; Zhang Y; Xiao P; Hua L; Leng L; Chen X; Bucala R
Clin Rheumatol; 2023 Feb; 42(2):443-451. PubMed ID: 36401063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
